US Patent

US10414751 — Antifungal compounds and processes for making

Composition of Matter · Assigned to Mycovia Pharmaceuticals Inc · Expires 2036-03-17 · 10y remaining

Vulnerability score 12/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects polymorphic forms of compound 1 or 1a and processes for preparing them, which are used as antifungal agents.

USPTO Abstract

The present invention relates to polymorphic forms of compound 1 or 1a and processes for preparing compound 1 and 1a polymorphs, which are useful as antifungal agents. In particular, the invention seeks to provide a new methodology for preparing polymorphs of compound 1 and substituted derivatives thereof.

Drugs covered by this patent

Patent Metadata

Patent number
US10414751
Jurisdiction
US
Classification
Composition of Matter
Expires
2036-03-17
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Mycovia Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.